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bstract
im  of  the  study.  –  The lack of traceability and monitoring of blood donors and transfused patients constitute a barrier to the most basic rules of
aemovigilance and overall good transfusion practices. This study draws up an inventory of knowledge, attitudes and clinical practice of blood
rescribers in Niamey.
aterials  and  methods.  –  A questionnaire was administered to 180 prescribers of blood products in Niamey in 2011. Questions were related to
asic informations on blood transfusion and clinical use of blood. Analyses were performed using SAS 9.3 version.
esults.  –  The sample consisted of 180 respondents from several professional categories: 51 physicians (28.33%), 10 medical students (5.56%), 84
urses (46.67%), 15 anaesthesiologist assistant (8.33%) and 20 midwives (11.11%). Among these, 22.2% received training in blood transfusion
afety. Half of the respondents (50.8%) got between 50 and 75% of correct answers, 45.8% got less than 50% correct while 3.35% scored more than
5% correct answers. The overall quality of responses was higher among physicians compared to other prescribers (P  < 0.0001); among respondents
ho received training in transfusion safety (P  < 0.0001); and among males (P  = 0.0306). For some items, subjects with more experience scored the
est.
onclusion.  –  The level of knowledge is still inadequate. More training in transfusion practices is necessary for prescribers of blood products.
ccompanying measures to improve transfusion practice must be considered or strengthened through assessments, knowledge update/upgrade
regular, ongoing training) and establishment of active and motivated hospital transfusion committees.
 2015 Elsevier Masson SAS. All rights reserved.
eywords: Blood safety; Clinical use of blood; Haemovigilance; Niamey
ésumé
ut  de  l’étude.  –  L’insuffisance de trac¸abilité et de suivi épidémiologique des donneurs de sang et des patients transfusés constituent une entrave
 l’hémovigilance et aux bonnes pratiques transfusionnelles en général. L’objectif de cette étude est d’établir un état des lieux des connaissances,
ttitudes et pratique clinique des prescripteurs de produits sanguins à Niamey.
atériel  et  méthode.  –  Un questionnaire a été soumis à 180 prescripteurs de produits sanguins à Niamey en 2011. Les questions étaient relatives
ux notions de base sur la transfusion ainsi qu’à l’utilisation clinique du sang. L’analyse a été effectuée grâce au logiciel SAS version 9.3.
ésultats.  –  L’enquête a concerné 51 médecins (28,3 %), 10 étudiants en médecine (5,6 %), 84 infirmiers (46,7 %), 15 aides-anesthésistes (8,3
) et 20 sages-femmes (11,1 %). Parmi ces sujets, 22,2 % ont rec¸u une formation en transfusion sanguine. La moitié des répondants (50,8 %) ont
u entre 50 et 75 % de bonnes réponses, 45,8 % moins de 50 %, et 3,35 %, plus de 75 %. La qualité globale des réponses était meilleure chez
es médecins comparés aux autres prescripteurs (p  < 0,0001), chez les participants qui ont rec¸u une formation en transfusion (p  < 0,0001) et chez
es hommes (p  = 0,0306). Pour certains items, les sujets ayant plus d’ancienneté professionnelle étaient meilleurs répondeurs.
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onclusion.  –  Le niveau des connaissances étant insuffisant, des formations en transfusion sont nécessaires pour les prescripteurs de produits
anguins. Des mesures d’accompagnement devraient être envisagées ou renforcées au moyen d’évaluations, de remises à niveau (formation
ontinue), et par la mise en place de comités hospitaliers de transfusion actifs et motivés.
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.  Introduction
Blood transfusion saves lives and improves health [1]. For
hat reason, nearly 108 million blood donations are collected
nnually worldwide [1]. However, this practice is not without
isk as it can lead to incidents or accidents for both the donor
nd the recipient. Haemovigilance was introduced in France in
he early 1990s [2,3] as a tool specifically dedicated to improving
uality and safety of transfusions [4].
Clearly defined as an epidemiological surveillance system
3], haemovigilance is also “a set of surveillance procedures cov-
ring the whole transfusion chain (from the collection of blood
nd its components to the follow-up of recipients), intended
o collect and assess information on unexpected or undesirable
ffects resulting from the therapeutic use of labile blood prod-
cts, and to prevent their occurrence or recurrence” [5]. This
onitoring and warning system is based on the traceability of
lood component and steps involved in the process from donor
o recipient and also relies on reporting of transfusion incidents
2]. Traceability, meanwhile, aims to help identify, from a blood
omponent number, either the donor whose blood was used to
repare the product, or the recipient to whom the blood was
dministered [6].
The existence, structure and operational statuses of
aemovigilance in a given country are correlated to the exis-
ence of an advanced transfusion system [4]. Thus, apart from
ocal or institutional initiatives, organized haemovigilance is vir-
ually inexistent in developing countries [4]. The same applies
or quality assurance systems that may control the transfusion
ractice [7]. In 2010, only 1.3% of hospitals in World Health
rganization (WHO) Africa Region conducted audits on blood
ransfusion, and only 26% were reporting transfusion incidents
8]. Similarly, less than one of 10 African countries have an
dequate policy on clinical use of blood [7].
At the Niamey Regional Blood Transfusion Centre (BTC),
uality assurance is being established gradually, but the lack of
raceability and epidemiological monitoring of blood donors and
ransfused patients constitute a barrier to the most basic rules of
aemovigilance and overall good transfusion practices. The dis-
ribution of labile blood components (LBC) is either nominative,
r, since 2011, as blood banking in three hospitals [Hôpi-
al National de Lamordé (HNL), Centre Hospitalier Régional
oudrière (CHR/P) and Maternité Issaka Gazobi (MIG)].
Blood units which are not transfused are retrieved by the BTC
nly under certain conditions of transport and storage. Because
f this situation, coupled with the chronic shortage of blood
nd medical emergency, clinicians tend to use these units for




he majority of services using LBC for transfusion purposes do
ot have a “transfusion registry”.
It should however be pointed out that, in 2005, the Ministry
f Public Health of Niger issued a decree on the establishment
f hospital transfusion committees (HTC) in reference hospitals
nd maternity wards, and in regional hospitals. But only two
nstitutions [Hôpital National de Niamey (HNN) and MIG, the
wo largest consumers of LBC] actually set up these committees
n 2007–2008, though they are still not functional. Under these
onditions, top-down and bottom-up transfusion investigations
emain very often uncertain if not illusive. The same applies
or post-transfusion infectious or immunological follow-up on
hort-, medium- or long-term patients.
This is the context in which, and the reason why, this study
as designed: to identify ways of improving the management
f LBC recipients. Its objective is to analyze the degree of
nowledge in transfusion practice, clinical attitudes and prac-
ices of LBC prescribers, especially regarding prescription of
lood components, transfusion rules, traceability, rational use
f blood and haemovigilance. The conclusions drawn from this
nalysis will probably lead to solutions aimed at improving
ransfusion practice in Niamey.
.  Materials  and  methods
.1.  Study  population
An individual questionnaire was submitted to prescribers of
lood components working in public or private care facilities
CF) in Niamey.
Sampling was done according to a non-probability technique.
articipation in the study was voluntary and anonymous. All
nstitutions that use transfusion were enrolled: pediatrics, mater-
ity wards, medicine, surgery, intensive care and emergency
ooms. Respondents interviewed between March and July 2011,
ere from 18 different CF.
.2.  Assessment  tool
To achieve the objectives of the study, an individual question-
aire was developed.
In the first part of the questionnaire, items were related to
he socio-professional characteristics of the subject: gender,
ccupation, facility, unit, specialty, seniority, training in blood
ransfusion practice. The questionnaire then focused on issues
elated to the knowledge of certain rules of good transfusion
ractices including: conservation and transportation of LBC,
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he ABO system, transfusion-related errors and hazards, com-
atibility concept, ABO control at the patient’s bedside, and
aemovigilance.
Another chapter of the questionnaire addressed issues related
o transfusion attitudes and practices: transfusion of a blood unit
o a patient to whom it was not originally intended, patient
onitoring during transfusion, traceability of the transfusion
rocess (and data recording including notification and report-
ng of transfusion-related incidents/accidents), and measures
onsidered for the rational use of blood.
The last part of the questionnaire was devoted to difficul-
ies experienced by physicians during their transfusion practice,
olutions to deal with them, as well as suggestions to improve
elations between CF and BTC.
Poorly filled questionnaires have been removed so that a total
umber of 180 valid questionnaires were analyzed.
.3.  Statistical  analysis
This was a cross-sectional study. After the data collection
rocess, answers received on the questionnaire were coded and
ntered into a database set up in Excel. They were then analyzed
sing SAS 9.3 version.
A descriptive analysis of the population was first performed.
ssociation between the percentages of correct answers and
ocio-professional characteristics of respondents was then mea-
ured.
The relationship between two qualitative variables was
nvestigated using the Chi2 test for contingency tables. The
elationship between a qualitative variable and a quantitative
ariable was studied using a one-way analysis of variance
ANOVA) for independent samples and the nonparametric
ruskal-Wallis test. Results were considered significant at a
evel of uncertainty of 5% (P  < 0.05).
.  Results
.1.  Description  of  the  study  population
The sample consisted of 180 respondents: 51 physicians
28.3%) including 38 general practitioners and 13 special-
sts, 10 medical students (5.56%), 84 nurses (46.7%), 15
naesthesiologist-assistants (8.3%) and 20 midwives (11.1%).
he respondents worked mostly in the public sector (75.6% in
ix CF) and in the private sector (24.4% in 13 CF). In terms
f gender, 40% were male and 60% female. Of the respondents,
.2% were unaware of a BTC in Niamey. About a fifth of the sub-
ects (22.2%) reported having received training on blood safety
nd rational use of blood.
.2.  Knowledge
.2.1.  Storage  of  blood  components
For 26.1% of respondents, whole blood bags can be stored in a
onventional household refrigerator. Of the 63.9% who knew the
hole blood should be stored in a refrigerator with a temperature
ontrol system, only 20% knew the whole blood [or concentrated
3
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rythrocyte (CE)] storage temperature (+2 to +6 ◦C). About 11%
f respondents knew platelets storage temperature. Fresh frozen
lasma (FFP) storage temperature is less well known (only 8%
f respondents). Overall, 87.8% of respondents did not know the
helf life of whole blood.
.3.  Immuno-hematology  concepts
With regard to ABO blood system, 40.6% of respondents
id not know why O-type is known as “universal donor”. Fur-
hermore, 73.9% of respondents did not know the existence of
lood group systems other than ABO. Only two out of the 180
espondents (1.1%) named, together with ABO, the five most
mmunogenic systems: RH, Kell, Duffy, Kidd and MNSs.
Among prescribers, 4.4% did not know that a compatibility
est is performed before a blood bag is delivered to a patient. Less
han a third of respondents (29.4%) knew what a compatible
ransfusion is. A similar percentage (30%), however, believed
hat a compatible transfusion is a transfusion with an iso-group
nd/or iso-Rhesus blood.
According to our study, 82.8% of respondents were unaware
hat two blood units of the same ABO-type may be incompatible;
nd 36.7% did not know that two different blood types (ABO)
an be compatible.
.3.1. Transfusion  risk
One in six respondents (16.7%) did not know that trans-
usion can be risky for the patient. For 8.3% of respondents,
ransfusion involved no risk for the recipient; and 68.3% of
espondents knew that most of transfusion accidents due to ABO
ncompatibility occur within 15 minutes after the initiation of the
ransfusion.
.3.2. Deﬁnition  of  haemovigilance
To define haemovigilance, the following proposals must be
hecked: “transfuse blood into a patient only when a compat-
bility test was carried out”, “monitor incidents occurring in
onors and/or blood recipients”, and “transfuse a patient only
f absolutely necessary”. Positive responses were collected in
uite similar proportions: 32.8, 33.3 and 33.9%, respectively.
he proportion of respondents who checked two proposals was
.9% and 5.6% of respondents checked the three proposals at
nce.
.4.  Attitudes  and  practices
.4.1.  Transfusion  errors
One in five (20%) claim to have transfused blood to a patient
ther than that for whom the blood was intended. Half of those
espondents reported performing this act regularly i.e., more
han once a month. The majority (97.2%) mentioned an emer-
ency to explain this practice and a minority (2.8%) mentioned
 transfusion error..4.2.  Immediate  monitoring  of  transfusion
In our study, 45% of respondents do not stay at the bedside
fter initiating a transfusion. Their unanimous explanation for













































Problems identified during transfusion practice as expressed by survey
participants.
Rate Wording
84.4% (principal problem) Non-availability of blood, sometimes
leading to death
10.2% (other problems) Inadequate training
Deadline for receipt of blood units is too
long
Unfair distribution of blood bags (BTC’s
parents and acquaintances are privileged)
No hospital blood bank





Lack of time for patient monitoring
Accessibility issues and remoteness from
the BTC
Not enough specialists (BTC) to contact
in case of problems
BTC staff not understanding
Poor quality of the reception (BTC), lack
of respect
Lack of transfusion sets and gloves










years in the profession) or experience in the field (number of
years as a LBC prescriber). However, considering each question
individually, for some items, the quality of responses is better
Table 2
Some recommendations made by respondents.
Train, retrain and supervise blood prescribers as well as the BTC staff
Rationalize blood orders
Raise awareness for blood donation and improve blood availability
Set up a blood bank in hospitals
Treat any demand for blood without discrimination
Improve the reception at the BTC
Provide transfusion sets and gloves
Listen to blood prescribers’ complaints
Establish a communication framework, ensure better collaboration
between BTC and CF
Hold periodic and regular meetings between BTC and CF
Establish an HTC in institutions conducting transfusion practicesZ. Mayaki et al. / Transfusion Cl
his was a lack of time due to understaffing. Among them, two
a nurse and a midwife) also said they used to delegate this task
o the person assisting the patient.
.4.3. Traceability  and  haemovigilance
Each blood components issued by the BTC is delivered with
 transfusion sheet. The sheet, which must be returned to the
TC once the transfusion is completed, is always (75%), some-
imes (7.8%) and never (17.2%) filled by respondents. Even
f filled, 23.9% are never returned to the BTC. A transfusion
egistry was available in 39.4% of respondents’ departments.
or 16.9% of them, the registry was not appropriately filled
up-to-date). In these registries, there was no field for the
otification of potential transfusion adverse events or reactions.
bserved reactions to transfusion have not been reported in
2.8% of the cases. Otherwise, only 10.3% of the notifications
f reactions to transfusion were sent to the BTC.
.4.4. Rational  use  of  blood
Our study showed that 28.9% of respondents answered “no”
o the following question: “Are all blood units issued by the
TC tranfused?” For 34.6% of them, these unused units are
eturned to the BTC within a suitable period of time (< 1 hour).
therwise (65.4% of the cases), these blood bags are kept in
he hospital refrigerator, waiting to be destroyed or transfused
o another patient without pre-transfusion compatibility. Nearly
/3 of respondents declared they did not know which method
o use if transfusion alternative had to be considered.
.4.5. Indications  for  transfusion
To the question “what are the major indications for the
ransfusions you perform?” Anemia, mentioned by 80% of
espondents, topped the list. Hemorrhage (10.9%) and surgery
9.1%) were also mentioned.
.4.6.  Difﬁculties  and  prospects
The respondents mentioned the main challenges they face in
ransfusion practice. Most of them (84.4%) lamented the non-
vailability of blood. Other problems were related to inadequate
raining, unfair distribution of blood bags, etc. (Table 1). The
espondents have subsequently made recommendations to deal
ith those difficulties (Table 2).
.5.  Measures  of  association
.5.1.  Training  in  blood  transfusion
The study showed a significant difference between subjects
ho received transfusion training and those who have not.
ndeed, the quality of responses (percentage of correct answers)
as higher in the first group (P  < 0.0001, Table 3).
.5.2. Profession
There is a significant difference (P  < 0.0001) between theuality of responses and occupation, and the quality of responses





TC: Blood Transfusion Centre; CF: care facilities.
.5.3.  Gender
The study results also showed that the overall quality of
esponses is better in men than in women (P  = 0.0306, Table 3).
mong non-physician prescribers, men were also the best
esponders (P  = 0.0329).
.5.4. Number  of  years  prescribing  blood  products
Considering all issues, the quality of responses (proportion
f correct answers) was not influenced by seniority (number ofnsure better management of transfusion sheets at both levels (BTC
and CF)
TC: Blood Transfusion Centre; CF: care facilities; HTC: hospital transfusion
ommittees.
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Table 3
Percentage of correct answers according to occupation, training in transfusion and gender.
Percentage correct
answers
Occupation Training in transfusion Gender Total prescribers
Doctor Other Yes No Male Female
n % n % n % n % n % n % n %
< 50 12 6.7 70 39.1 15 37.5 67 48.2 20 27.4 62 58.5 82 45.8
50–75 45 25.1 46 25.7 21 52.5 70 50.4 50 68.5 41 38.9 91 50.8
≥ 75 5 2.8 1 0.6 4 10.0 2 1.44 3 4.11 3 2.83 6 3.4
































































o value < 0.0001 in favour of doctors < 0.0001 in fav
A: not applicable.
a One missing data.
P  < 0.05) in subjects with more seniority or experience in the
eld. These items are: definition of haemovigilance, storage
f whole blood or CE, pre-transfusion compatibility for each
lood unit, and the occurrence of transfusion accidents due to
BO incompatibility within minutes following initiation of the
ransfusion.
.  Discussion
This survey is instructive with regard to the weakness of
nowledge about transfusion among caregivers in Niamey.
lood transfusion acts require the supervision of a physician;
ut, given the lack of clinicians in Niger in general, physicians,
urses and midwives are blood prescribers. Thus, discussion of
ur survey results will reflect the overall quality of responses
ithout group distinction.
.1.  Transfusion  indications
The results of the study were consistent with data from exist-
ng literature regarding indications for transfusion in developing
ountries. Indeed, up to 80% of transfusions that are performed
n Sub-Saharan Africa are a result of anemia or haemorrhage [9].
.2.  Blood  units  storage
Inadequate knowledge of the LBC storage conditions partly
xplains the conservation of the blood units in a household
efrigerator. This unsafe practice can lead to the development
f infectious agents (especially bacteria) in the blood bag or to
n inefficient transfusion. Given that all clinical departments do
ot have adequate refrigerators for blood bags storage, the best
lternative would be that the unused blood bags are returned
o the BTC within one hour after receipt, in accordance with a
ritten procedure developed for this purpose.
.3.  Basics  of  immunohaematology
Consequences of an incompatible transfusion (especially
BO error) are the most dangerous in transfusion practice.
ndeed, besides being inefficient, ABO incompatibility is uni-
ersally recognized as a major cause of morbidity and mortality
10]; CE volumes of greater than 50 mL are associated with a
4
uf trained 0.0306 in favour of men NA
ethality of 20% [11]. Although knowledge in immunohaema-
ology is particularly significant with the blood bank staff
ho LBC’ prescribers often blindly trust, medical staff, espe-
ially nurses who administer blood, should also definitely be
cquainted with transfusion rules. Disregard for these rules as
roved by our investigation remains unquestionably a major con-
ern, given that ABO compatibility rules are the basis of any
ransfusion.
.4.  Transfusion  errors  and  close  supervision  of  transfusion
Transfusion without any compatibility test and, in addition,
o patient for whom it was not intended, still considerably
ncrease the immunological transfusion risk. This may lead to
he death of the recipient, especially for ABO-incompatible
ransfusion. Knowing that, in most cases, the signs related to
BO-incompatible transfusions occur in the first minutes fol-
owing the initiation of the transfusion, close monitoring for
linical signs at the bedside is indicated. It is indeed frequently
ithin this short period of time that can be observed signs of
ntolerance with potential harm to the blood recipient. These
igns are justification for stopping the transfusion [12]. Unfor-
unately, in this survey, almost half of respondents reported not
eing able to take the right approach due to a lack of staff in the
F.
.5.  Transfusion  risk
With 8.3% of the respondents for whom transfusion is never
angerous and 16.7% who claimed not to know that transfu-
ion may be risky, 25% (one quarter) of blood prescribers are
naware that blood transfusion may be associated with adverse
eactions. This proportion is lower than that (36.4%) recorded
n Mali by Diakité et al. in 2010 [13]. Thus, as the potential haz-
rds of transfusion are largely misunderstood, the precautionary
easures necessary to ensure transfusion safety might not be
bserved..6.  Traceability  and  haemovigilance
This study also reveals that haemovigilance is relatively
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ntegrate this concept and its implications for future training in
lood transfusion safety targeted to LBC prescribers.
The non-availability of a transfusion registry in many depart-
ents defeats the traceability concept since it is difficult or
ven impossible to connect the LBC with the recipient and vice
ersa. Removal of outdated blood bags from hospitals are not
ecorded, reinforcing our concern regarding traceability and the
ational use of LBC. Thus, it becomes clear that identification,
llocation and monitoring of transfusion risks are not feasible,
nd the side effects associated with transfusion cannot be
ppreciated. Such settings, combined with the difficulty of
onitoring a patient after admission, make it almost impossible
o investigate any incident or accident occurring at any step of
he transfusion chain.
.7.  Difﬁculties  encountered  (by  respondents)  and  rational
se of  blood
Although the large majority of respondents has lamented
bout blood shortages, our survey showed that for approximately
0% of the respondents; blood units issued by the BTC were not
sed, pointing out unnecessary blood demands. This practice
nly makes the situation worse as the BTC faces difficulties to
eet the blood requirements with only 45% of the demand met
n 2012 and 2013 and 58% in 2014 (BTC data). This is a vicious
ircle where prescribers, because of the shortage, tend to order
ore than necessary in order to either keep a little stock for the
epartment, or to have one or two additional blood units for the
atient. According to Tinmouth et al. [14], increased knowledge
f clinicians in transfusion practice would benefit a more ratio-
al use of LBC. Note that, with about four blood donations per
000 inhabitants in 2010 [8] (compared to 36.8‰ in more devel-
ped countries [15]), blood shortage is persistent in low-income
ountries, and barely half of the requirements can be met [8].
ailure to return unused unit (to the BTC) could be justified by
he remoteness of some CF, which therefore cannot meet the
rescribed period of one hour to return unused blood bags as
ecommended by the related procedure.
Further difficulties have also been cited but to a lesser extent.
owever, they are matters of great importance when one knows
or instance, that the reputation of poor reception attributed
o the BTC staff is legendary in the public health institutions
n Niger (and Africa in general [16]) where it represents an
mpediment for the use of public services. These difficulties are
ide-ranging: organizational, behavioral, cognitive and techni-
al/operational.
Given the difficulties mentioned by respondents, we real-
ze that both the BTC (mainly) and the CF are responsible for
ransfusion shortcomings.
.8.  Outlook  (according  to  respondents)
Creating a framework for knowledge sharing between BTC
nd CF, including the establishment of HTC, place high on
he list of recommendations made by prescribers. It should be
ointed out that 10 years ago, the Ministry of Health issued a
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ate, none is functional. This is mainly due to the high turnover
ate of staff (reassignments, departure for other more financially
ttractive structures, transfer of CF managers to other institu-
ions), and leads to an endless cycle and often restarting over.
here may be potential explanations for these committees not
eing functional; however, we know very little about them.
To overcome unfairness in delivering blood components,
espondents suggested that there be no more discrimination. This
spect, although unethical, is probably related to the shortage of
BC causing some of the demand for blood components can-
ot be met by the BTC. Respondents also suggested expanding
raining for the BTC staff citing their incompetence.
.9.  Training  in  blood  transfusion  and  gender
The proportion of subjects who received training in blood
ransfusion (22.2%) in our study is comparable to that (29.1%)
ecorded in Mali in 2010 [13] and the Democratic Republic of
ongo in 2011 (25.5%) [17] in relatively similar surveys. Unlike
iakité et al. [13] and similarly to Kabinda et al. [17], the results
f our study showed that the quality of responses was better
mong prescribers who received training in blood transfusion.
hus, as already shown by Tramalloni et al. [18], transfusion
ractice in hospitals could be improved if training is widely pro-
ided/strengthened to blood prescribers. Female health workers
hould also be sensitized because, although we were not able
o establish the reasons, they were found to be less efficient
han male workers. Therefore, training sessions organized by
he BTC should more than ever be encouraged. Since 2006 and
ith the support of partners (European Union, WHO, Global
und), the BTC has organized several training sessions in blood
afety and rational use of blood for the LBC prescribers. Then,
he BTC made available in hospitals guidelines in good practices
or transfusion practice (Clinical guide to transfusion). In light
f these assessments, in order to improve transfusion practice in
ospitals and ensure sustainability, follow-up to these training
ourses is useful through field-based assessments and retraining
hen required. The establishment or strengthening of a quality
pproach in health services should also be encouraged [19,20].
ll these actions would help guide the choice of corrective action
n order to adopt the best approach towards transfusion.
.10.  Profession
Although predictable, the highest scores recorded in the
hysicians’ group showed that their presence at the bedside
ould be beneficial when a transfusion is considered or initi-
ted. In the study by Diakité et al. [13] in Mali, nurses and
idwives, also had the most inadequate knowledge. Similarly,
or Kabinda et al., doctors were the best responders for some
tems [17]. Our survey showed that, unfortunately, monitoring
f transfusion is often delegated to nurses and midwives as a
esult of a lack of practitioners. This option is completely possi-
le but these professional caregivers said they were themselves
verworked (burned out). In 2012, the Niger doctor to popu-
ation ratio was 1:16,307 (1:6774 in Niamey), nurse to patient
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or 3710 women of childbearing potential (1:832 in Niamey);
he standard recommended by WHO is 1:10,000 for doctors;
:5000 for nurses and midwives [21]. From a professional and
thical point of view, the attitude to be condemned is the dele-
ation of patient monitoring to a relative assisting the patient.
owever, as it is very likely that the latter is not a health officer
r is not educated, he might not recognize life-threatening signs
n the blood recipient.
.11.  Seniority
Not surprisingly, our results also showed that seniority is a
actor promoting the quality of responses, although there is much
o be done.
.12.  Expected  impact
The results of this survey could strengthen the BTC strategy
mplemented to improve the traceability of blood components
nd to establish haemovigilance in Niamey. Indeed, the National
olicy for Blood Transfusion of Niger advocates to ensure the
raceability of all blood components, thereby linking donor to
ecipient and vice versa in order to adopt adequate measures
n case of incident/accident (national blood transfusion policy
iger, 2006). This will only be possible through training of
nvolved staff and improving coordination of CF/BTC activities.
o this end, implementation of transfusion committee in hospi-
als is more relevant than ever. Unlike Sub-Saharan Africa, many
tudies have been conducted in developed countries [22–25] or
n Maghreb countries [26–28] to assess knowledge and prac-
ices (of hospital staff) in medical transfusion practice. These
tudies have identified shortcomings (regarding knowledge, atti-
udes and practices) and recommended strengthening training
nd monitoring or implementation of other appropriate measures
quality assurance, audit.  .  .). On this basis, we strongly encour-
ge surveys to measure the knowledge on medical transfusion
ractice in Sub-Saharan Africa.
.13.  Study  limitations
Our study has limitations. The participation rate could not be
etermined because the questionnaires have not been quantified
t the time the survey was distributed. Respondents had consid-
red the questionnaire lengthy (10 pages); and response times
ere particularly long. Exhaustive sampling was intended but
ew (two) clinics did not participate in the study.
.  Conclusion
The study highlighted weaknesses in knowledge and short-
omings in transfusion practice in hospitals in Niamey. The need
or training was expressed by the respondents themselves and
as felt through their answers. Nevertheless, to be effective,raining should be supported by measures to consolidate the
chievements. Indeed, it would be illusory to think that training,
s a stand-alone strategy, may be sufficient to ensure blood safety
n hospitals. Thus, to ensure the effects and impacts of initiatives
[ et Biologique 23 (2016) 78–85
arried out to promote safety at all levels of the transfusion chain,
udits should be conducted regularly, and appropriate corrective
ctions should be implemented.
isclosure  of  interest
The authors declare that they have no competing interest.
cknowledgements
Thanks to all individuals who contributed in drafting the
uestionnaire.
Thanks to all directors of hospitals and clinics; all senior
edical officers and their staff; and all nursing staffs who helped
obilize the study participants and contributed in data collec-
ion.
eferences
[1] World Health Organization. Blood safety and availability, fact
sheet No. 279; 2015 [Available at: http://www.who.int/mediacentre/
factsheets/fs279/en/, Accessed on 15/06/2015].
[2] Delbosc A, Weiller J, Dussert P. L’hémovigilance à l’aube du XXIe siècle.
Presse Med 2000;29:1066–71.
[3] Salmi LR, Hervé P. L’organisation de l’hémovigilance en France. Transfus
Clin Biol 1994;1:252–6.
[4] Faber JC. Revue des principaux systèmes d’hémovigilance dans le monde.
Transfus Clin Biol 2009;16:86–92.
[5] IHN (International Haemovigilance Network). Definition of Haemovig-
ilance from International Hemovigilance Network; 2010 [Available at:
http://www.ihn-org.com/about/definition-of-haemovigilance/, Accessed
on 13/07/2015].
[6] Articles R. 666-12-11 et R. 666-12-13 du Code de la santé publique. Cir-
culaire DGS/DH no 40 du 7 juillet 1994 relative au décret no 94-68 du 14
janvier 1994 sur l’hémovigilance pris pour application de l’article L. 666-
12 du Code de la santé publique; 1994 [Available at: http://ansm.sante.fr/
var/ansm site/storage/original/application/4cf777a3baf517ffae58785
a0abd996a.pdf, Accessed on 31 mars 2015].
[7] Tagny CT, Mbanya D, Tapko JB, Lefrère JJ. Blood safety in Sub-Saharan
Africa: a multi-factorial problem. Transfusion 2008;48:1256–61.
[8] Tapko JB, Toure B, Sambo LG. Status of blood safety in the WHO African
region. Report of the 2010 survey. Brazzaville; 2014 [Available at: http://
www.afro.who.int/en/clusters-a-programmes/hss/blood-safety-
laboratories-a-health-technology.html, Accessed on 08/04/2015].
[9] Allain JP, Owusu-Ofori S, Bates I. Blood transfusion in sub-Saharan Africa.
Transfus Altern Transfus Med 2004;6:16–23.
10] David B. Bilan et perspectives du fonctionnement de l’hémovigilance
franc¸aise et des données recueillies sur 9 ans. Transfus Clin Biol
2003;10:131–9.
11] Janatpour KA, Kalmin ND, Jensen HM, Holland PV. Clinical outcomes of
ABO-incompatible RBC transfusions. Am J Clin Pathol 2008;129:276–81.
12] Andreu G. Du bon usage des produits sanguins. Presse Med
2015;44:165–77.
13] Diakité M, Diawara SI, Tchogang NT, Fofana DB, Diakité SA, Doumbia
S, et al. Connaissances et attitudes du personnel médical en matière de
transfusion sanguine au Mali. Transfus Clin Biol 2012;19:74–7.
14] Tinmouth A, Macdougall L, Fergusson D, Amin M, Graham ID, Hebert
PC, et al. Reducing the amount of blood transfused: a systematic review of
behavioral interventions to change physicians’ transfusion practices. Arch
Intern Med 2005;165:845–52.
15] World Health Organization. 10 facts on blood transfusion; 2015 [Avail-
able at: http://www.who.int/features/factfiles/blood transfusion/blood













[Z. Mayaki et al. / Transfusion Cl
16] Jaffré Y. Une médecine inhospitalière : les difficiles relations entre
soignants et soignés dans cinq capitales d’Afrique de l’Ouest. KARTHALA
Éditions; 2003.
17] Kabinda JM, Miyanga SA, Donnen P, Van den Ende J, Dramaix MW.
Knowledge, attitudes and practices of medical and paramedical staff in
blood transfusion in the Democratic Republic of Congo. Open J Prev Med
2014;4:672–80.
18] Tramalloni D, Aupérin A, Oubouzar N, Lapierre V. Implication du
personnel infirmier dans la sécurité transfusionnelle : évaluation des
connaissances et de la pratique à l’institut Gustave-Roussy. Transfus Clin
Biol 2005;12:427–32.
19] Le Drezen L, Lepiouf L, Léostic C, Barra JA, Le Niger C. Démarche qualité
en hémovigilance : analyse du processus transfusionnel. Transfus Clin Biol
2004;11:138–45.
20] Hergon E, Guez P, Lopez R, Cabaud JJ, Garnerin P, Rouger P. Amélio-
ration de la sécurité transfusionnelle dans un établissement de santé par
le développement d’une démarche qualité. Transfus Clin Biol 1996;3:
305–14.21] République du Niger, Ministère de la Santé Publique. Annuaire des statis-
tiques sanitaires pour 2012 (ratio personnel de santé par région p22); 2013
[Available at: http://snis.cermes.net/download/Ann stat 2012 Niger.pdf,
Accessed on 08/04/2015].
[ et Biologique 23 (2016) 78–85 85
22] Le Cosquer P. Enquête sur les pratiques des médecins anesthésistes-
réanimateurs en transfusion sanguine et en hémovigilance. Ann Fr Anesth
2000;19:485–91.
23] Salem-Schatz SR, Avorn J, Soumerai SB. Influence of clinical knowledge,
organizational context, and practice style on transfusion decision making:
implications for practice change strategies. JAMA 1990;264:476–83.
24] Salem-Schatz SR, Avorn J, Soumerai SB. Influence of knowledge and
attitudes on the quality of physicians’ transfusion practice. Med Care
1993;31:868–78.
25] Rock G, Berger R, Pinkerton P, Fernandes B. A pilot study to assess physi-
cian knowledge in transfusion medicine. Transfusion Med 2002;12:125–8.
26] Letaief M, Hassine M, Bejia I, Romdhane FB, Salem KB, Soltani MS.
Connaissances et pratiques du personnel soignant en matière de sécurité
transfusionnelle. Transfus Clin Biol 2005;12:25–9.
27] Salah NB, El Borgi W, Skhiri HA, Lakhal FB, Mouelhi H, Zoueri B,
et al. Connaissances médicales en matière de sécurité immunologique en
transfusion érythrocytaire en Tunisie : évaluation d’un CD-ROM d’auto-
enseignement. Transfus Clin Biol 2013;20:448–53.28] Lahlimi FZ, Tazi I, Sifsalam M, Bouchtia M, Mahmal L. Évaluation de la
pratique transfusionnelle : enquête au sein du personnel infirmier du centre
d’oncologie-hématologie du CHU Mohammed VI de Marrakech, Maroc.
Transfus Clin Biol 2015;22:12–6.
